Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inhibition of dual leucine zipper kinase prevents chemotherapy-induced peripheral neuropathy and cognitive impairments
Jiacheng Ma, Sunil Goodwani, Paul Acton, et al.
Pain (2021) Vol. 162, Iss. 10, pp. 2599-2612
Open Access | Times Cited: 20

Showing 20 citing articles:

Mitochondrial Superoxide Dismutase in Cisplatin-Induced Kidney Injury
Kranti A. Mapuskar, Emily J. Steinbach, Amira Zaher, et al.
Antioxidants (2021) Vol. 10, Iss. 9, pp. 1329-1329
Open Access | Times Cited: 42
Novel inhibitors of acute, axonal DLK palmitoylation are neuroprotective and avoid the deleterious side effects of cell-wide DLK inhibition
Xiaotian Zhang, Hey‐Kyeong Jeong, Jingwen Niu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 6
Stress‐induced vesicular assemblies of dual leucine zipper kinase are signaling hubs involved in kinase activation and neurodegeneration
Elena Tortosa, Arundhati Sengupta Ghosh, Qingling Li, et al.
The EMBO Journal (2022) Vol. 41, Iss. 14
Open Access | Times Cited: 24
Discovery of IACS-52825, a Potent and Selective DLK Inhibitor for Treatment of Chemotherapy-Induced Peripheral Neuropathy
Kang Le, Michael Soth, Jason B. Cross, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9954-9971
Closed Access | Times Cited: 14
Inhibiting acute, axonal DLK palmitoylation is neuroprotective and avoids deleterious effects of cell-wide DLK inhibition
Xiaotian Zhang, Hey‐Kyeong Jeong, Jingwen Niu, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Pyruvate kinase deficiency links metabolic perturbations to neurodegeneration and axonal protection
Thomas J. Waller, Catherine A. Collins, Monica Dus
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Regulation of the Activity of the Dual Leucine Zipper Kinase by Distinct Mechanisms
Kyra-Alexandra Köster, Marten Dethlefs, Jorge Duque Escobar, et al.
Cells (2024) Vol. 13, Iss. 4, pp. 333-333
Open Access | Times Cited: 3
Contributions of neuroimmune interactions to chemotherapy-induced peripheral neuropathy development and its prevention/therapy
Jenna Ollodart, Laiton R Steele, E. Alfonso Romero‐Sandoval, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116070-116070
Closed Access | Times Cited: 2
Neuroimaging based biotypes for precision diagnosis and prognosis in cancer-related cognitive impairment
Shelli R. Kesler, Ashley M. Henneghan, Sarah Prinsloo, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 5
In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury
H. Rachel Lagiakos, Yefen Zou, Hideyuki Igawa, et al.
(2024)
Open Access | Times Cited: 1
Neurotoxicity in Cancer Survivorship: The Significance of Cancer-Related Cognitive Impairment and Chemotherapy-Induced Peripheral Neuropathy
Ellen M. Lavoie Smith, Diane Von Ah
Seminars in Oncology Nursing (2024) Vol. 40, Iss. 5, pp. 151724-151724
Closed Access | Times Cited: 1
In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury
H. Rachel Lagiakos, Yefen Zou, Hideyuki Igawa, et al.
(2024)
Open Access | Times Cited: 1
In Silico Enabled Discovery of KAI-11101, a Preclinical DLK Inhibitor for the Treatment of Neurodegenerative Disease and Neuronal Injury
H. Rachel Lagiakos, Yefen Zou, Hideyuki Igawa, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 1
Dual Leucine Zipper Kinase Regulates Dscam Expression through a Noncanonical Function of the Cytoplasmic Poly(A)-Binding Protein
Monika Singh, Bing Ye, Jung Hwan Kim
Journal of Neuroscience (2022) Vol. 42, Iss. 31, pp. 6007-6019
Open Access | Times Cited: 7
Grape-Seed-Derived Procyanidin Attenuates Chemotherapy-Induced Cognitive Impairment by Suppressing MMP-9 Activity and Related Blood–Brain-Barrier Damage
Chao Song, Chao Gao, Zhenxin Wang
Brain Sciences (2022) Vol. 12, Iss. 5, pp. 571-571
Open Access | Times Cited: 6
Deciphering the multifunctional role of dual leucine zipper kinase (DLK) and its therapeutic potential in disease
Haiqing Bu, Zhijia Li, Yingying Lu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 255, pp. 115404-115404
Closed Access | Times Cited: 3
The Molecular Mechanisms Involved in Axonal Degeneration and Retrograde Retinal Ganglion Cell Death
Zhaoyang Zuo, Zi-Yuan Zhang, Si‐Ming Zhang, et al.
DNA and Cell Biology (2023) Vol. 42, Iss. 11, pp. 653-667
Closed Access | Times Cited: 2
Examining Cognitive Performance in Mice using the Open-Source Operant Feeding Device FED3
Laura B. Murdaugh, Brieann Brown, Chin‐Hui Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Platinum-based chemotherapy: trends in organic nanodelivery systems
João A. V. Santos, Daniela Silva, M. Paula M. Marques, et al.
Nanoscale (2024) Vol. 16, Iss. 31, pp. 14640-14686
Closed Access
Connexin 43 mediated mitochondrial transfer prevents cisplatin induced sensory neurodegeneration.
Rebecca Owen, Jack Corbett, Mark J. Paul‐Clark, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Characterization of Novel SARM1 Inhibitors for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Jiayu Chen, Hao Li
Biomedicines (2024) Vol. 12, Iss. 9, pp. 2123-2123
Open Access
Page 1

Scroll to top